Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2010

View Archived Issues

Emory University discloses new subunit-selective NMDA receptor agonists

KPT-127 inhibits tumor growth in vivo in xenograft model

TAK-438 shows promise to treat acid-related diseases

MannKind provides Afrezza for Artificial Pancreas Project

Bayer Schering claims new adenosine A1 receptor agonists

NeuroSearch presents new modulators of nicotinic acetylcholine receptors

Phase IIb data support use of tasocitinib as immunosuppressant in kidney transplant recipients

Roche and Aileron Therapeutics join to develop stapled peptide drugs

FDA clears Prolor Biotech's IND for phase II trial of hGH-CTP

Daiichi Sankyo presents new cyclic amino alcohols for autoimmune conditions

New GlyT-1 inhibitors described by AstraZeneca

New hepatocyte growth factor receptor inhibitors claimed by sanofi-aventis

Raptor Pharmaceuticals provides clinical program update

Isotechnika and 3SBio sign agreement for voclosporin in China

FDA grants fast track status to ThermoDox for HCC

Vyteris to license Georgia Tech's transdermal drug delivery technologies

Cerus regains commercial rights to Intercept blood system from BioOne

Cellonis reports on use of stem cell therapy to treat child with diabetes

Strativa launches Oravig in U.S. for oropharyngeal candidiasis

Human neural stem cell transplants restore function in model of chronic spinal cord injury

Daiichi requests approval to manufacture and market denosumab in Japan

Clinuvel plans pilot trial of Scenesse in vitiligo

Upsher-Smith acquires U.S. marketing rights to Vagifem 10 mcg

Taligen Therapeutics advances TT30 program

Synta Pharma begins phase I trial of STA-9090/docetaxel combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...